nodes	percent_of_prediction	percent_of_DWPC	metapath
Butabarbital—CHRNA4—autonomic nervous system—type 2 diabetes mellitus	0.0132	0.244	CbGeAlD
Butabarbital—CHRNA4—peripheral nervous system—type 2 diabetes mellitus	0.00956	0.176	CbGeAlD
Butabarbital—GRIK2—nerve—type 2 diabetes mellitus	0.00927	0.171	CbGeAlD
Butabarbital—CHRNA4—nerve—type 2 diabetes mellitus	0.00745	0.137	CbGeAlD
Butabarbital—Thiamylal—KCNJ11—type 2 diabetes mellitus	0.00393	0.3	CrCbGaD
Butabarbital—Dermatitis—Miglitol—type 2 diabetes mellitus	0.0039	0.00567	CcSEcCtD
Butabarbital—GRIK2—retina—type 2 diabetes mellitus	0.00384	0.0706	CbGeAlD
Butabarbital—Tension—Glimepiride—type 2 diabetes mellitus	0.00377	0.00548	CcSEcCtD
Butabarbital—Tension—Sitagliptin—type 2 diabetes mellitus	0.00376	0.00546	CcSEcCtD
Butabarbital—Nervousness—Glimepiride—type 2 diabetes mellitus	0.00373	0.00542	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Losartan—type 2 diabetes mellitus	0.00372	0.00541	CcSEcCtD
Butabarbital—Nervousness—Sitagliptin—type 2 diabetes mellitus	0.00372	0.00541	CcSEcCtD
Butabarbital—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.00369	0.00537	CcSEcCtD
Butabarbital—Syncope—Glipizide—type 2 diabetes mellitus	0.00369	0.00537	CcSEcCtD
Butabarbital—Nausea—Miglitol—type 2 diabetes mellitus	0.00367	0.00534	CcSEcCtD
Butabarbital—Loss of consciousness—Glipizide—type 2 diabetes mellitus	0.00362	0.00526	CcSEcCtD
Butabarbital—Angioedema—Pioglitazone—type 2 diabetes mellitus	0.0036	0.00524	CcSEcCtD
Butabarbital—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00358	0.00521	CcSEcCtD
Butabarbital—Agitation—Glimepiride—type 2 diabetes mellitus	0.00353	0.00513	CcSEcCtD
Butabarbital—Angioedema—Glimepiride—type 2 diabetes mellitus	0.00351	0.0051	CcSEcCtD
Butabarbital—Rash—Tolbutamide—type 2 diabetes mellitus	0.00351	0.0051	CcSEcCtD
Butabarbital—Angioedema—Sitagliptin—type 2 diabetes mellitus	0.0035	0.00509	CcSEcCtD
Butabarbital—Anxiety—Glipizide—type 2 diabetes mellitus	0.00349	0.00508	CcSEcCtD
Butabarbital—Headache—Tolbutamide—type 2 diabetes mellitus	0.00348	0.00507	CcSEcCtD
Butabarbital—Constipation—Repaglinide—type 2 diabetes mellitus	0.00347	0.00505	CcSEcCtD
Butabarbital—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00345	0.00502	CcSEcCtD
Butabarbital—Tension—Bromocriptine—type 2 diabetes mellitus	0.0034	0.00494	CcSEcCtD
Butabarbital—Confusional state—Glipizide—type 2 diabetes mellitus	0.00339	0.00492	CcSEcCtD
Butabarbital—Loss of consciousness—Glimepiride—type 2 diabetes mellitus	0.00337	0.00491	CcSEcCtD
Butabarbital—Nervousness—Bromocriptine—type 2 diabetes mellitus	0.00336	0.00489	CcSEcCtD
Butabarbital—Dizziness—Tolazamide—type 2 diabetes mellitus	0.00335	0.00487	CcSEcCtD
Butabarbital—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.00335	0.00487	CcSEcCtD
Butabarbital—Bradycardia—Gliclazide—type 2 diabetes mellitus	0.00332	0.00484	CcSEcCtD
Butabarbital—Nausea—Tolbutamide—type 2 diabetes mellitus	0.0033	0.00481	CcSEcCtD
Butabarbital—Shock—Glipizide—type 2 diabetes mellitus	0.0033	0.0048	CcSEcCtD
Butabarbital—Ataxia—Losartan—type 2 diabetes mellitus	0.0033	0.0048	CcSEcCtD
Butabarbital—Constipation—Rosiglitazone—type 2 diabetes mellitus	0.00328	0.00477	CcSEcCtD
Butabarbital—Anxiety—Glimepiride—type 2 diabetes mellitus	0.00326	0.00474	CcSEcCtD
Butabarbital—Anxiety—Sitagliptin—type 2 diabetes mellitus	0.00325	0.00472	CcSEcCtD
Butabarbital—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.00322	0.00468	CcSEcCtD
Butabarbital—Rash—Tolazamide—type 2 diabetes mellitus	0.00319	0.00464	CcSEcCtD
Butabarbital—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00319	0.00464	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Ramipril—type 2 diabetes mellitus	0.00319	0.00464	CcSEcCtD
Butabarbital—Agitation—Bromocriptine—type 2 diabetes mellitus	0.00318	0.00463	CcSEcCtD
Butabarbital—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00317	0.00461	CcSEcCtD
Butabarbital—Headache—Tolazamide—type 2 diabetes mellitus	0.00317	0.00461	CcSEcCtD
Butabarbital—Confusional state—Glimepiride—type 2 diabetes mellitus	0.00316	0.00459	CcSEcCtD
Butabarbital—Rash—Linagliptin—type 2 diabetes mellitus	0.00316	0.00459	CcSEcCtD
Butabarbital—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00316	0.00459	CcSEcCtD
Butabarbital—Headache—Linagliptin—type 2 diabetes mellitus	0.00314	0.00456	CcSEcCtD
Butabarbital—CHRNA7—retina—type 2 diabetes mellitus	0.00313	0.0575	CbGeAlD
Butabarbital—Syncope—Bromocriptine—type 2 diabetes mellitus	0.00311	0.00452	CcSEcCtD
Butabarbital—Dizziness—Nateglinide—type 2 diabetes mellitus	0.0031	0.00451	CcSEcCtD
Butabarbital—Vomiting—Acarbose—type 2 diabetes mellitus	0.00309	0.0045	CcSEcCtD
Butabarbital—Shock—Glimepiride—type 2 diabetes mellitus	0.00308	0.00448	CcSEcCtD
Butabarbital—Rash—Acarbose—type 2 diabetes mellitus	0.00307	0.00446	CcSEcCtD
Butabarbital—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00306	0.00445	CcSEcCtD
Butabarbital—Loss of consciousness—Bromocriptine—type 2 diabetes mellitus	0.00304	0.00443	CcSEcCtD
Butabarbital—Nausea—Tolazamide—type 2 diabetes mellitus	0.00301	0.00437	CcSEcCtD
Butabarbital—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00301	0.00437	CcSEcCtD
Butabarbital—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00299	0.00435	CcSEcCtD
Butabarbital—Somnolence—Glipizide—type 2 diabetes mellitus	0.00298	0.00434	CcSEcCtD
Butabarbital—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00298	0.00434	CcSEcCtD
Butabarbital—Rash—Nateglinide—type 2 diabetes mellitus	0.00296	0.0043	CcSEcCtD
Butabarbital—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00295	0.0043	CcSEcCtD
Butabarbital—Anxiety—Bromocriptine—type 2 diabetes mellitus	0.00294	0.00427	CcSEcCtD
Butabarbital—Hypotension—Glimepiride—type 2 diabetes mellitus	0.00293	0.00426	CcSEcCtD
Butabarbital—Angioedema—Glyburide—type 2 diabetes mellitus	0.00289	0.00421	CcSEcCtD
Butabarbital—Nausea—Acarbose—type 2 diabetes mellitus	0.00289	0.0042	CcSEcCtD
Butabarbital—Constipation—Glipizide—type 2 diabetes mellitus	0.00287	0.00418	CcSEcCtD
Butabarbital—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.00285	0.00415	CcSEcCtD
Butabarbital—Tension—Gliclazide—type 2 diabetes mellitus	0.00279	0.00406	CcSEcCtD
Butabarbital—Somnolence—Glimepiride—type 2 diabetes mellitus	0.00279	0.00405	CcSEcCtD
Butabarbital—Nausea—Nateglinide—type 2 diabetes mellitus	0.00278	0.00405	CcSEcCtD
Butabarbital—Bradycardia—Metformin—type 2 diabetes mellitus	0.00278	0.00405	CcSEcCtD
Butabarbital—Shock—Bromocriptine—type 2 diabetes mellitus	0.00278	0.00404	CcSEcCtD
Butabarbital—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.00278	0.00404	CcSEcCtD
Butabarbital—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.00277	0.00402	CcSEcCtD
Butabarbital—Nervousness—Gliclazide—type 2 diabetes mellitus	0.00276	0.00402	CcSEcCtD
Butabarbital—Constipation—Sitagliptin—type 2 diabetes mellitus	0.00267	0.00388	CcSEcCtD
Butabarbital—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.00265	0.00385	CcSEcCtD
Butabarbital—CHRNA7—cardiovascular system—type 2 diabetes mellitus	0.00265	0.0487	CbGeAlD
Butabarbital—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00264	0.00384	CcSEcCtD
Butabarbital—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.00263	0.00382	CcSEcCtD
Butabarbital—Agitation—Gliclazide—type 2 diabetes mellitus	0.00261	0.0038	CcSEcCtD
Butabarbital—CHRNA4—cardiovascular system—type 2 diabetes mellitus	0.00261	0.048	CbGeAlD
Butabarbital—Confusional state—Glyburide—type 2 diabetes mellitus	0.00261	0.00379	CcSEcCtD
Butabarbital—Angioedema—Gliclazide—type 2 diabetes mellitus	0.0026	0.00378	CcSEcCtD
Butabarbital—CHRNA7—kidney—type 2 diabetes mellitus	0.00259	0.0476	CbGeAlD
Butabarbital—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.00258	0.00376	CcSEcCtD
Butabarbital—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00258	0.00375	CcSEcCtD
Butabarbital—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.00257	0.00374	CcSEcCtD
Butabarbital—Rash—Repaglinide—type 2 diabetes mellitus	0.00256	0.00372	CcSEcCtD
Butabarbital—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00256	0.00372	CcSEcCtD
Butabarbital—Headache—Repaglinide—type 2 diabetes mellitus	0.00254	0.0037	CcSEcCtD
Butabarbital—Shock—Glyburide—type 2 diabetes mellitus	0.00254	0.0037	CcSEcCtD
Butabarbital—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00254	0.00369	CcSEcCtD
Butabarbital—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.00251	0.00365	CcSEcCtD
Butabarbital—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.0025	0.00363	CcSEcCtD
Butabarbital—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00247	0.0036	CcSEcCtD
Butabarbital—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00242	0.00352	CcSEcCtD
Butabarbital—Constipation—Bromocriptine—type 2 diabetes mellitus	0.00242	0.00352	CcSEcCtD
Butabarbital—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00242	0.00351	CcSEcCtD
Butabarbital—Hypotension—Glyburide—type 2 diabetes mellitus	0.00241	0.00351	CcSEcCtD
Butabarbital—Anxiety—Gliclazide—type 2 diabetes mellitus	0.00241	0.00351	CcSEcCtD
Butabarbital—Nausea—Repaglinide—type 2 diabetes mellitus	0.00241	0.00351	CcSEcCtD
Butabarbital—Headache—Rosiglitazone—type 2 diabetes mellitus	0.0024	0.00349	CcSEcCtD
Butabarbital—Angioedema—Valsartan—type 2 diabetes mellitus	0.00239	0.00347	CcSEcCtD
Butabarbital—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00237	0.00345	CcSEcCtD
Butabarbital—Angioedema—Orlistat—type 2 diabetes mellitus	0.00236	0.00343	CcSEcCtD
Butabarbital—Syncope—Valsartan—type 2 diabetes mellitus	0.00234	0.00341	CcSEcCtD
Butabarbital—Confusional state—Gliclazide—type 2 diabetes mellitus	0.00234	0.0034	CcSEcCtD
Butabarbital—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.00233	0.00339	CcSEcCtD
Butabarbital—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00231	0.00336	CcSEcCtD
Butabarbital—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.0023	0.00335	CcSEcCtD
Butabarbital—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.0023	0.00334	CcSEcCtD
Butabarbital—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00228	0.00331	CcSEcCtD
Butabarbital—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00223	0.00325	CcSEcCtD
Butabarbital—Dizziness—Glipizide—type 2 diabetes mellitus	0.00222	0.00323	CcSEcCtD
Butabarbital—Anxiety—Valsartan—type 2 diabetes mellitus	0.00222	0.00322	CcSEcCtD
Butabarbital—Tension—Irbesartan—type 2 diabetes mellitus	0.0022	0.0032	CcSEcCtD
Butabarbital—Anxiety—Orlistat—type 2 diabetes mellitus	0.00219	0.00318	CcSEcCtD
Butabarbital—Nervousness—Irbesartan—type 2 diabetes mellitus	0.00218	0.00317	CcSEcCtD
Butabarbital—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00217	0.00315	CcSEcCtD
Butabarbital—Vomiting—Glipizide—type 2 diabetes mellitus	0.00213	0.0031	CcSEcCtD
Butabarbital—Syncope—Metformin—type 2 diabetes mellitus	0.00213	0.0031	CcSEcCtD
Butabarbital—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00213	0.0031	CcSEcCtD
Butabarbital—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00213	0.00309	CcSEcCtD
Butabarbital—Rash—Glipizide—type 2 diabetes mellitus	0.00212	0.00308	CcSEcCtD
Butabarbital—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00212	0.00308	CcSEcCtD
Butabarbital—Headache—Glipizide—type 2 diabetes mellitus	0.0021	0.00306	CcSEcCtD
Butabarbital—Shock—Valsartan—type 2 diabetes mellitus	0.0021	0.00305	CcSEcCtD
Butabarbital—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.00209	0.00304	CcSEcCtD
Butabarbital—Tension—Losartan—type 2 diabetes mellitus	0.00207	0.00301	CcSEcCtD
Butabarbital—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00207	0.00301	CcSEcCtD
Butabarbital—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00207	0.003	CcSEcCtD
Butabarbital—Agitation—Irbesartan—type 2 diabetes mellitus	0.00206	0.003	CcSEcCtD
Butabarbital—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00206	0.003	CcSEcCtD
Butabarbital—Nervousness—Losartan—type 2 diabetes mellitus	0.00205	0.00298	CcSEcCtD
Butabarbital—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00205	0.00298	CcSEcCtD
Butabarbital—Headache—Pioglitazone—type 2 diabetes mellitus	0.00202	0.00293	CcSEcCtD
Butabarbital—Syncope—Irbesartan—type 2 diabetes mellitus	0.00201	0.00293	CcSEcCtD
Butabarbital—Nausea—Glipizide—type 2 diabetes mellitus	0.00199	0.0029	CcSEcCtD
Butabarbital—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00199	0.0029	CcSEcCtD
Butabarbital—Hypotension—Valsartan—type 2 diabetes mellitus	0.00199	0.0029	CcSEcCtD
Butabarbital—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00199	0.00289	CcSEcCtD
Butabarbital—Constipation—Gliclazide—type 2 diabetes mellitus	0.00198	0.00289	CcSEcCtD
Butabarbital—Rash—Glimepiride—type 2 diabetes mellitus	0.00198	0.00287	CcSEcCtD
Butabarbital—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00197	0.00287	CcSEcCtD
Butabarbital—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.00197	0.00287	CcSEcCtD
Butabarbital—Rash—Sitagliptin—type 2 diabetes mellitus	0.00197	0.00286	CcSEcCtD
Butabarbital—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00197	0.00286	CcSEcCtD
Butabarbital—Headache—Glimepiride—type 2 diabetes mellitus	0.00196	0.00285	CcSEcCtD
Butabarbital—Headache—Sitagliptin—type 2 diabetes mellitus	0.00196	0.00285	CcSEcCtD
Butabarbital—Agitation—Losartan—type 2 diabetes mellitus	0.00194	0.00282	CcSEcCtD
Butabarbital—Angioedema—Losartan—type 2 diabetes mellitus	0.00193	0.00281	CcSEcCtD
Butabarbital—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00191	0.00278	CcSEcCtD
Butabarbital—Shock—Metformin—type 2 diabetes mellitus	0.00191	0.00278	CcSEcCtD
Butabarbital—Anxiety—Irbesartan—type 2 diabetes mellitus	0.0019	0.00277	CcSEcCtD
Butabarbital—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.0019	0.00277	CcSEcCtD
Butabarbital—Somnolence—Valsartan—type 2 diabetes mellitus	0.0019	0.00276	CcSEcCtD
Butabarbital—Syncope—Losartan—type 2 diabetes mellitus	0.00189	0.00276	CcSEcCtD
Butabarbital—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00187	0.00272	CcSEcCtD
Butabarbital—Nausea—Glimepiride—type 2 diabetes mellitus	0.00186	0.00271	CcSEcCtD
Butabarbital—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.00186	0.0027	CcSEcCtD
Butabarbital—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00186	0.0027	CcSEcCtD
Butabarbital—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00183	0.00267	CcSEcCtD
Butabarbital—Constipation—Valsartan—type 2 diabetes mellitus	0.00182	0.00265	CcSEcCtD
Butabarbital—Hypotension—Metformin—type 2 diabetes mellitus	0.00181	0.00264	CcSEcCtD
Butabarbital—Shock—Irbesartan—type 2 diabetes mellitus	0.0018	0.00262	CcSEcCtD
Butabarbital—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.0018	0.00261	CcSEcCtD
Butabarbital—Anxiety—Losartan—type 2 diabetes mellitus	0.00179	0.00261	CcSEcCtD
Butabarbital—Rash—Bromocriptine—type 2 diabetes mellitus	0.00178	0.00259	CcSEcCtD
Butabarbital—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00178	0.00259	CcSEcCtD
Butabarbital—Tension—Ramipril—type 2 diabetes mellitus	0.00178	0.00259	CcSEcCtD
Butabarbital—Headache—Bromocriptine—type 2 diabetes mellitus	0.00177	0.00258	CcSEcCtD
Butabarbital—Nervousness—Ramipril—type 2 diabetes mellitus	0.00176	0.00256	CcSEcCtD
Butabarbital—Confusional state—Losartan—type 2 diabetes mellitus	0.00174	0.00253	CcSEcCtD
Butabarbital—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.00174	0.00252	CcSEcCtD
Butabarbital—Somnolence—Metformin—type 2 diabetes mellitus	0.00173	0.00251	CcSEcCtD
Butabarbital—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00171	0.00249	CcSEcCtD
Butabarbital—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00171	0.00249	CcSEcCtD
Butabarbital—Shock—Losartan—type 2 diabetes mellitus	0.0017	0.00247	CcSEcCtD
Butabarbital—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00168	0.00244	CcSEcCtD
Butabarbital—Thiopental—CYP2E1—type 2 diabetes mellitus	0.00167	0.128	CrCbGaD
Butabarbital—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00167	0.00242	CcSEcCtD
Butabarbital—Agitation—Ramipril—type 2 diabetes mellitus	0.00166	0.00242	CcSEcCtD
Butabarbital—Constipation—Metformin—type 2 diabetes mellitus	0.00166	0.00241	CcSEcCtD
Butabarbital—Angioedema—Ramipril—type 2 diabetes mellitus	0.00166	0.00241	CcSEcCtD
Butabarbital—Vomiting—Glyburide—type 2 diabetes mellitus	0.00164	0.00239	CcSEcCtD
Butabarbital—Rash—Glyburide—type 2 diabetes mellitus	0.00163	0.00237	CcSEcCtD
Butabarbital—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00163	0.00237	CcSEcCtD
Butabarbital—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00163	0.00237	CcSEcCtD
Butabarbital—Syncope—Ramipril—type 2 diabetes mellitus	0.00162	0.00236	CcSEcCtD
Butabarbital—Headache—Glyburide—type 2 diabetes mellitus	0.00162	0.00235	CcSEcCtD
Butabarbital—Hypotension—Losartan—type 2 diabetes mellitus	0.00161	0.00234	CcSEcCtD
Butabarbital—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.0016	0.00233	CcSEcCtD
Butabarbital—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.00159	0.00232	CcSEcCtD
Butabarbital—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00157	0.00228	CcSEcCtD
Butabarbital—Constipation—Irbesartan—type 2 diabetes mellitus	0.00157	0.00228	CcSEcCtD
Butabarbital—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00155	0.00226	CcSEcCtD
Butabarbital—Anxiety—Ramipril—type 2 diabetes mellitus	0.00154	0.00224	CcSEcCtD
Butabarbital—Nausea—Glyburide—type 2 diabetes mellitus	0.00153	0.00223	CcSEcCtD
Butabarbital—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00153	0.00223	CcSEcCtD
Butabarbital—Somnolence—Losartan—type 2 diabetes mellitus	0.00153	0.00223	CcSEcCtD
Butabarbital—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.00151	0.0022	CcSEcCtD
Butabarbital—Confusional state—Ramipril—type 2 diabetes mellitus	0.00149	0.00217	CcSEcCtD
Butabarbital—Phenobarbital—ABCC2—type 2 diabetes mellitus	0.00148	0.113	CrCbGaD
Butabarbital—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00148	0.00215	CcSEcCtD
Butabarbital—Constipation—Losartan—type 2 diabetes mellitus	0.00147	0.00214	CcSEcCtD
Butabarbital—Rash—Gliclazide—type 2 diabetes mellitus	0.00146	0.00213	CcSEcCtD
Butabarbital—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00146	0.00213	CcSEcCtD
Butabarbital—Shock—Ramipril—type 2 diabetes mellitus	0.00145	0.00212	CcSEcCtD
Butabarbital—Headache—Gliclazide—type 2 diabetes mellitus	0.00145	0.00211	CcSEcCtD
Butabarbital—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.00145	0.00211	CcSEcCtD
Butabarbital—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00142	0.00207	CcSEcCtD
Butabarbital—Dizziness—Valsartan—type 2 diabetes mellitus	0.00141	0.00205	CcSEcCtD
Butabarbital—Secobarbital—CYP1A2—type 2 diabetes mellitus	0.0014	0.107	CrCbGaD
Butabarbital—Dizziness—Orlistat—type 2 diabetes mellitus	0.00139	0.00203	CcSEcCtD
Butabarbital—Hypotension—Ramipril—type 2 diabetes mellitus	0.00138	0.00201	CcSEcCtD
Butabarbital—Nausea—Gliclazide—type 2 diabetes mellitus	0.00138	0.002	CcSEcCtD
Butabarbital—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00136	0.00198	CcSEcCtD
Butabarbital—Vomiting—Valsartan—type 2 diabetes mellitus	0.00136	0.00197	CcSEcCtD
Butabarbital—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00135	0.00196	CcSEcCtD
Butabarbital—Rash—Valsartan—type 2 diabetes mellitus	0.00134	0.00195	CcSEcCtD
Butabarbital—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00134	0.00195	CcSEcCtD
Butabarbital—Vomiting—Orlistat—type 2 diabetes mellitus	0.00134	0.00195	CcSEcCtD
Butabarbital—Headache—Valsartan—type 2 diabetes mellitus	0.00134	0.00194	CcSEcCtD
Butabarbital—Rash—Orlistat—type 2 diabetes mellitus	0.00133	0.00193	CcSEcCtD
Butabarbital—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00133	0.00193	CcSEcCtD
Butabarbital—Headache—Orlistat—type 2 diabetes mellitus	0.00132	0.00192	CcSEcCtD
Butabarbital—Somnolence—Ramipril—type 2 diabetes mellitus	0.00131	0.00191	CcSEcCtD
Butabarbital—Dizziness—Metformin—type 2 diabetes mellitus	0.00128	0.00187	CcSEcCtD
Butabarbital—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00127	0.00185	CcSEcCtD
Butabarbital—Nausea—Valsartan—type 2 diabetes mellitus	0.00127	0.00184	CcSEcCtD
Butabarbital—Constipation—Ramipril—type 2 diabetes mellitus	0.00126	0.00184	CcSEcCtD
Butabarbital—Nausea—Orlistat—type 2 diabetes mellitus	0.00125	0.00182	CcSEcCtD
Butabarbital—Vomiting—Metformin—type 2 diabetes mellitus	0.00123	0.0018	CcSEcCtD
Butabarbital—Rash—Metformin—type 2 diabetes mellitus	0.00122	0.00178	CcSEcCtD
Butabarbital—Dermatitis—Metformin—type 2 diabetes mellitus	0.00122	0.00178	CcSEcCtD
Butabarbital—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.00122	0.00177	CcSEcCtD
Butabarbital—Headache—Metformin—type 2 diabetes mellitus	0.00122	0.00177	CcSEcCtD
Butabarbital—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00121	0.00176	CcSEcCtD
Butabarbital—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.00117	0.0017	CcSEcCtD
Butabarbital—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00116	0.00169	CcSEcCtD
Butabarbital—Rash—Irbesartan—type 2 diabetes mellitus	0.00116	0.00168	CcSEcCtD
Butabarbital—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00115	0.00168	CcSEcCtD
Butabarbital—Nausea—Metformin—type 2 diabetes mellitus	0.00115	0.00168	CcSEcCtD
Butabarbital—Headache—Irbesartan—type 2 diabetes mellitus	0.00115	0.00167	CcSEcCtD
Butabarbital—Dizziness—Losartan—type 2 diabetes mellitus	0.00114	0.00166	CcSEcCtD
Butabarbital—Vomiting—Losartan—type 2 diabetes mellitus	0.0011	0.00159	CcSEcCtD
Butabarbital—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00109	0.00158	CcSEcCtD
Butabarbital—Nausea—Irbesartan—type 2 diabetes mellitus	0.00109	0.00158	CcSEcCtD
Butabarbital—Rash—Losartan—type 2 diabetes mellitus	0.00109	0.00158	CcSEcCtD
Butabarbital—Dermatitis—Losartan—type 2 diabetes mellitus	0.00109	0.00158	CcSEcCtD
Butabarbital—Headache—Losartan—type 2 diabetes mellitus	0.00108	0.00157	CcSEcCtD
Butabarbital—Thiopental—CYP3A4—type 2 diabetes mellitus	0.00105	0.0804	CrCbGaD
Butabarbital—Phenobarbital—CYP2E1—type 2 diabetes mellitus	0.00104	0.0794	CrCbGaD
Butabarbital—Nausea—Losartan—type 2 diabetes mellitus	0.00102	0.00149	CcSEcCtD
Butabarbital—Phenobarbital—CYP1A2—type 2 diabetes mellitus	0.000989	0.0755	CrCbGaD
Butabarbital—Dizziness—Ramipril—type 2 diabetes mellitus	0.000978	0.00142	CcSEcCtD
Butabarbital—Vomiting—Ramipril—type 2 diabetes mellitus	0.00094	0.00137	CcSEcCtD
Butabarbital—Rash—Ramipril—type 2 diabetes mellitus	0.000932	0.00136	CcSEcCtD
Butabarbital—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000931	0.00135	CcSEcCtD
Butabarbital—Headache—Ramipril—type 2 diabetes mellitus	0.000926	0.00135	CcSEcCtD
Butabarbital—Nausea—Ramipril—type 2 diabetes mellitus	0.000878	0.00128	CcSEcCtD
Butabarbital—Pentobarbital—CYP3A4—type 2 diabetes mellitus	0.000874	0.0668	CrCbGaD
Butabarbital—GABRB2—Neuronal System—ABCC8—type 2 diabetes mellitus	0.000728	0.00297	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000714	0.00292	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.000713	0.00291	CbGpPWpGaD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—type 2 diabetes mellitus	0.00071	0.0029	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—type 2 diabetes mellitus	0.000709	0.00289	CbGpPWpGaD
Butabarbital—GABRB2—Ion channel transport—ATP2A2—type 2 diabetes mellitus	0.000707	0.00288	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000697	0.00284	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.000692	0.00282	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—type 2 diabetes mellitus	0.000687	0.00281	CbGpPWpGaD
Butabarbital—GABRB2—Ion channel transport—TRPC6—type 2 diabetes mellitus	0.000686	0.0028	CbGpPWpGaD
Butabarbital—GABRA1—Orphan transporters—PLAT—type 2 diabetes mellitus	0.000685	0.0028	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000682	0.00278	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000674	0.00275	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000669	0.00273	CbGpPWpGaD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—type 2 diabetes mellitus	0.000667	0.00272	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—ABCC8—type 2 diabetes mellitus	0.000666	0.00272	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—GAD2—type 2 diabetes mellitus	0.000664	0.00271	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.000664	0.00271	CbGpPWpGaD
Butabarbital—Phenobarbital—CYP3A4—type 2 diabetes mellitus	0.000655	0.05	CrCbGaD
Butabarbital—CHRNA7—Neuronal System—SNAP25—type 2 diabetes mellitus	0.00065	0.00265	CbGpPWpGaD
Butabarbital—GABRG2—Ion channel transport—ATP2A2—type 2 diabetes mellitus	0.000646	0.00264	CbGpPWpGaD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—type 2 diabetes mellitus	0.000646	0.00264	CbGpPWpGaD
Butabarbital—GABRB2—Orphan transporters—APOB—type 2 diabetes mellitus	0.000644	0.00263	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—GAD2—type 2 diabetes mellitus	0.000637	0.0026	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000634	0.00259	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—type 2 diabetes mellitus	0.000632	0.00258	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.00063	0.00257	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.00063	0.00257	CbGpPWpGaD
Butabarbital—GABRG2—Ion channel transport—TRPC6—type 2 diabetes mellitus	0.000627	0.00256	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000622	0.00254	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000621	0.00254	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—type 2 diabetes mellitus	0.000613	0.0025	CbGpPWpGaD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—type 2 diabetes mellitus	0.000607	0.00248	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000605	0.00247	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.000598	0.00244	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000596	0.00243	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—PPP2CA—type 2 diabetes mellitus	0.000592	0.00242	CbGpPWpGaD
Butabarbital—GABRG2—Orphan transporters—APOB—type 2 diabetes mellitus	0.000589	0.0024	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—ABCC8—type 2 diabetes mellitus	0.000582	0.00238	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—GAD2—type 2 diabetes mellitus	0.000582	0.00238	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.000582	0.00238	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.000576	0.00235	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000565	0.00231	CbGpPWpGaD
Butabarbital—GABRA1—Ion channel transport—ATP2A2—type 2 diabetes mellitus	0.000565	0.00231	CbGpPWpGaD
Butabarbital—GABRA1—Ion channel transport—TRPC6—type 2 diabetes mellitus	0.000548	0.00224	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000546	0.00223	CbGpPWpGaD
Butabarbital—GABRB2—Orphan transporters—PPARA—type 2 diabetes mellitus	0.000543	0.00222	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—type 2 diabetes mellitus	0.000543	0.00222	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.000541	0.00221	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—IRS2—type 2 diabetes mellitus	0.00054	0.00221	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.000536	0.00219	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—GNB3—type 2 diabetes mellitus	0.000534	0.00218	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000534	0.00218	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000533	0.00218	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—type 2 diabetes mellitus	0.000532	0.00217	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—SNAP25—type 2 diabetes mellitus	0.00053	0.00216	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.000527	0.00215	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—type 2 diabetes mellitus	0.000526	0.00215	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000522	0.00213	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000517	0.00211	CbGpPWpGaD
Butabarbital—GABRA1—Orphan transporters—APOB—type 2 diabetes mellitus	0.000515	0.0021	CbGpPWpGaD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—type 2 diabetes mellitus	0.00051	0.00208	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—GAD2—type 2 diabetes mellitus	0.000509	0.00208	CbGpPWpGaD
Butabarbital—GRIK2—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000501	0.00205	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000497	0.00203	CbGpPWpGaD
Butabarbital—GABRG2—Orphan transporters—PPARA—type 2 diabetes mellitus	0.000497	0.00203	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—type 2 diabetes mellitus	0.000495	0.00202	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000493	0.00201	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.00049	0.002	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—type 2 diabetes mellitus	0.000487	0.00199	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—GNB3—type 2 diabetes mellitus	0.000486	0.00198	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000485	0.00198	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.00048	0.00196	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.00048	0.00196	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000476	0.00194	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000475	0.00194	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—type 2 diabetes mellitus	0.000474	0.00194	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—IRS1—type 2 diabetes mellitus	0.000472	0.00193	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000461	0.00188	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—KCNJ11—type 2 diabetes mellitus	0.00046	0.00188	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000456	0.00186	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000455	0.00186	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000439	0.00179	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000439	0.00179	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000439	0.00179	CbGpPWpGaD
Butabarbital—GABRA1—Orphan transporters—PPARA—type 2 diabetes mellitus	0.000434	0.00177	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—type 2 diabetes mellitus	0.000434	0.00177	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000433	0.00177	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	0.000428	0.00175	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNB3—type 2 diabetes mellitus	0.000426	0.00174	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000418	0.0017	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000414	0.00169	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—SNAP25—type 2 diabetes mellitus	0.00041	0.00168	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—CALM1—type 2 diabetes mellitus	0.000409	0.00167	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—GNB3—type 2 diabetes mellitus	0.000408	0.00167	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000408	0.00167	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—type 2 diabetes mellitus	0.000408	0.00166	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000402	0.00164	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.0004	0.00163	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000398	0.00162	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—PIK3R1—type 2 diabetes mellitus	0.000396	0.00162	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—GNB3—type 2 diabetes mellitus	0.000396	0.00162	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000396	0.00162	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000392	0.0016	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000392	0.0016	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.00039	0.00159	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.00039	0.00159	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000385	0.00157	CbGpPWpGaD
Butabarbital—GRIK2—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000384	0.00157	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000384	0.00157	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000384	0.00157	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000383	0.00157	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—type 2 diabetes mellitus	0.000383	0.00156	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ADCY5—type 2 diabetes mellitus	0.000379	0.00155	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000377	0.00154	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000377	0.00154	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.000375	0.00153	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000375	0.00153	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—RELA—type 2 diabetes mellitus	0.000373	0.00152	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—type 2 diabetes mellitus	0.000373	0.00152	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—CALM1—type 2 diabetes mellitus	0.000372	0.00152	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000372	0.00152	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.00037	0.00151	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.000366	0.00149	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000364	0.00149	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000358	0.00146	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000358	0.00146	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000357	0.00146	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000353	0.00144	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000351	0.00143	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	0.000351	0.00143	CbGpPWpGaD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—type 2 diabetes mellitus	0.00035	0.00143	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—PRKCB—type 2 diabetes mellitus	0.00035	0.00143	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000345	0.00141	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000345	0.00141	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000342	0.0014	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000339	0.00138	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—CASP3—type 2 diabetes mellitus	0.000336	0.00137	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.000335	0.00137	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—SNAP25—type 2 diabetes mellitus	0.000328	0.00134	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000326	0.00133	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—type 2 diabetes mellitus	0.000326	0.00133	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000321	0.00131	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	0.00032	0.00131	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	0.000319	0.0013	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—NFKB1—type 2 diabetes mellitus	0.000315	0.00128	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000313	0.00128	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000313	0.00128	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000313	0.00128	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—CALM1—type 2 diabetes mellitus	0.000313	0.00128	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.00031	0.00126	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—GNB3—type 2 diabetes mellitus	0.000307	0.00125	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000306	0.00125	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—type 2 diabetes mellitus	0.000306	0.00125	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.000306	0.00125	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000305	0.00125	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—CALM1—type 2 diabetes mellitus	0.000303	0.00124	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000301	0.00123	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000301	0.00123	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000297	0.00121	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000296	0.00121	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000294	0.0012	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000293	0.0012	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—SRC—type 2 diabetes mellitus	0.000293	0.0012	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000288	0.00118	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	0.000286	0.00117	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	0.000285	0.00116	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000285	0.00116	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000283	0.00116	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—GNB3—type 2 diabetes mellitus	0.00028	0.00114	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.00028	0.00114	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000274	0.00112	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000273	0.00112	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	0.000273	0.00111	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000271	0.00111	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.000263	0.00108	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	0.00026	0.00106	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000258	0.00105	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000256	0.00105	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—ADCY5—type 2 diabetes mellitus	0.00025	0.00102	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000248	0.00101	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000246	0.001	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000246	0.001	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—GNB3—type 2 diabetes mellitus	0.000245	0.001	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	0.000245	0.001	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.00024	0.00098	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000239	0.000974	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000237	0.000969	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000237	0.000969	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000236	0.000962	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—CALM1—type 2 diabetes mellitus	0.000235	0.000959	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	0.00023	0.00094	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000225	0.000918	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000225	0.000918	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	0.000223	0.000908	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000221	0.000901	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	0.00022	0.000899	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.00022	0.000896	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—ADCY5—type 2 diabetes mellitus	0.000218	0.000892	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000218	0.000891	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000217	0.000886	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—CALM1—type 2 diabetes mellitus	0.000215	0.000877	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000209	0.000854	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000206	0.000841	CbGpPWpGaD
Butabarbital—GABRG2—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000202	0.000824	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.0002	0.000814	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000197	0.000803	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000197	0.000803	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.000192	0.000783	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000191	0.000781	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000191	0.000781	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000191	0.000779	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.00019	0.000774	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.000189	0.000773	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—CALM1—type 2 diabetes mellitus	0.000188	0.000766	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000182	0.000745	CbGpPWpGaD
Butabarbital—GRIA2—BDNF signaling pathway—AKT1—type 2 diabetes mellitus	0.000182	0.000743	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	0.00018	0.000733	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	0.000177	0.000723	CbGpPWpGaD
Butabarbital—GABRA1—Neuronal System—PRKCB—type 2 diabetes mellitus	0.000176	0.00072	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000175	0.000714	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000167	0.000683	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000165	0.000673	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000164	0.00067	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000163	0.000664	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	0.000161	0.000656	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000159	0.000651	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000157	0.000642	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000153	0.000624	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000151	0.000616	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.00015	0.000613	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000149	0.000607	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000147	0.0006	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000144	0.000587	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	0.000138	0.000562	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000134	0.000549	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.000133	0.000541	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000132	0.000538	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000131	0.000536	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.00013	0.000531	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000126	0.000513	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	0.000124	0.000508	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.000121	0.000495	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000117	0.00048	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	0.000114	0.000464	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	0.000111	0.000454	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.000106	0.000433	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	9.94e-05	0.000406	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	9.85e-05	0.000402	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	9.01e-05	0.000368	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	7.88e-05	0.000322	CbGpPWpGaD
